Life Sciences

We guide life sciences companies through capital, IP, regulatory, commercialization and litigation challenges with practical, business-focused legal solutions.
Key Contacts
Sonshine AaronHussey DominiqueMichael Iande Grandpre VincentWoodin Cheryl
Droplet in beaker

Overview

We understand the unique challenges of the life sciences industry and the sophisticated needs of our innovative clients.

Clients trust us to provide practical advice at every stage: from securing capital and leveraging intellectual property to obtaining regulatory approvals, commercializing products, and defending against product liability and intellectual property claims. We also assist with executing strategic transactions and accessing public markets. 

,,The Bennett Jones team is incredibly responsive, as well as pragmatic in their approach to resolving issues.,,

What Clients Say

Our national team delivers business-focused solutions and pragmatic legal support to companies across various industries, including pharmaceuticals, medical devices, biotechnology, environmental science, natural health products, food processing and more. Our clients range from global corporations to emerging start-ups, and everything in between. 

,,They are experienced and skilled to easily navigate complex issues and present context and options to our team.,,

What Clients Say

How We Help

M&A and Capital Markets

Intellectual Property

Product Regulation

Product Liability and Class Action Litigation

Intellectual Property Litigation

International Arbitration

Commercial Transactions and International Trade

Competition & Antitrust

Cannabis

Client Work

BioSig Technologies

in its US$770 million business combination with Streamex Exchange, a commodities tokenization

Leede Jones Gable

in the C$8.1-million bought-deal public offering of units of Ventripoint Diagnostics

Alliance Global Partners

in a US$30-million public offering of units pursuant to a prospectus supplement with Cybin

Bloom Burton and Haywood Securities

in a US$150-million private placement of common shares of Cybin

Breathe Biomedical

in its proposed listing on NASDAQ and the TSX

BriaCell

in its public offering of common shares for gross proceeds of USD$3,050,000

BriaCell

in its securities law matters, including corporate finance, corporate governance, continuous disclosure, equity compensation and stock exchange requirements

BriaCell

in the spin-out of BriaPro Therapeutics

Concept Medical

in its acquisition by Functionalab Group and Dermapure

Cantor Fitzgerald Canada

in an up to US$35-million at-the-market equity program for the sale of common shares pursuant to an equity distribution agreement with Cybin

Corus Orthodontists

one of North America’s largest orthodontic partner networks, in various corporate matters

Extendicare

in its agreement to sell its retirement living operations comprised of 1,048 retirement living suites across eleven retirement communities in Ontario and Saskatchewan, to SiennaSabra ...
Read More

ICLS Dermatology

one of Canada's leading medical aesthetics clinics, in its acquisition by MedSpa Partners

Kensington Capital Partners and Kensington Private Equity Fund

in the C$35-million acquisition and related financing through its portfolio company, Clearpoint Health Network, of the surgical and medical centres business of Centric Health and subsequent reorganization of Clearpoint

Medicus Pharma

in its recent Canadian listing, establishment of a US$50-million shelf prospectus with the Ontario Securities Commission, and proposed US listing

Medicus Pharma

in its US IPO and NASDAQ-listing

Mimi's Rock

in its C$30-million acquisition by FitLife Brands by way of plan of arrangement as well as ongoing corporate, M&A, securities, real estate and governance advice

MustGrow Biologics

in connection with the filing of a base shelf prospectus relating to the offering for sale, from time to time, of common shares, warrants, units, debt securities, subscription receipts ...
Read More

MustGrow Biologics

in a joint venture with Bayer to develop sustainable organic biologicals in Europe, Asia Pacific, Middle East and Africa

MustGrow Biologics

in its non-brokered private placement for gross proceeds of C$7.1 million

Northern Health Authority

in the Mills Memorial Hospital Redevelopment Project

Northern Health Authority

in the Stuart Lake Hospital Redevelopment Project serving Fort St. James and surrounding First Nations communities

Numinus Wellness

in the establishment of a shelf prospectus for proceeds of C$150 million

Reunion Neuroscience

in its acquisition and take-private transaction with MPM BioImpact

Skandinaviska Enskilda Banken AB

as joint lead arranger and joint bookrunner in term loan facilities totalling C$385 million and C$125 million revolving credit facility made to a corporation in the medical technology industry

Solve FSHD Holdings

as lead investor with Cambrian Biopharma in Vita Therapeutics' US$31-million Series B equity financing

Stifel Nicolaus Canada

in the C$2.8-million overnight marketed offering of Mydecine Innovations Group

United Active Living

in matters related to ownership and operations of assisting living housing projects

VIVO Cannabis

in its $50 million all-equity business combination with MediPharm Labs

Recognitions

Chambers Canada

Competition/Antitrust
Corporate/M&A and Product Liability 
Dispute Resolution: Class Action (Defence)
Intellectual Property Litigation
Life Sciences

Chambers Global

International Trade/WTO
Corporate/M&A; Competition/Antitrust
Capital Markets
Intellectual Property

Chambers Canada Awards

Named Class Action Law Firm of the Year

Legal 500 Canada

Ranked in Corporate/M&A, International Trade/WTO, Competition/Antitrust, Capital Markets and Intellectual Property


Canadian Legal Lexpert Directory

Most Frequently Recommended, Class Actions (Toronto); Corporate Commercial Law (Calgary); Corporate Finance & Securities (Calgary); Mergers & Acquisitions (Calgary); Litigation - Product Liability (Toronto)
Consistently Recommended, Class Actions (Calgary); Corporate Commercial Law (Toronto, Vancouver); Competition Law (Calgary, Toronto); Corporate Finance & Securities (Toronto); Intellectual Property (Calgary, Edmonton, Toronto); Mergers & Acquisitions (Toronto)
Repeatedly Recommended, Mergers & Acquisitions (Vancouver); Litigation - Product Liability (Calgary)

Subscribe to our Quarterly Life Sciences


   

Dominique T. Hussey

Chief Executive Officer  •   Co-Head of Innovation, Technology & Branding Practice

Cheryl M. Woodin

Partner  •   Co-Head of Litigation and Dispute Resolution Department

Blog

The Impact of Global Trade on the Life Sciences Sector

May 26, 2026
Alison G. FitzGeraldNasra Moumin
Alison G. FitzGerald & Nasra Moumin
Update

Life Sciences Outlook 2026

May 26, 2026
Vincent M. de GrandpréMelissa M. Dimilta
Vincent M. de Grandpré & Melissa M. Dimilta
Blog

Life Sciences Collaborations and the Risk of Joint Patent Infringement

May 26, 2026
Emily P. KettelVincent M. de Grandpré
Emily P. Kettel & Vincent M. de Grandpré
Blog

The Life Sciences Boom: H2 2026 Outlook

May 26, 2026
Aaron E. Sonshine
Aaron E. Sonshine
Blog

Transfer Pricing Rules in Canada

May 26, 2026
Jehad HaymourJulia Qian WangAnna Lekach
Jehad Haymour, Julia Qian Wang & Anna Lekach

At the centre of market-shaping deals and high-stakes disputes, Bennett Jones delivers clarity, strategy and results. Our cross-border teams turn complexity into progress, always focused on what drives your success.

The Bennett Jones Story

At Bennett Jones, legal solutions are our starting point. What drives us forward is knowing our clients inside and out—their ambitions, obstacles and success metrics.

For more than a century, we have shaped outcomes that matter in business, in law and in the broader Canadian landscape. And our commitment extends beyond legal matters: we invest deeply in the communities in which we live and work.